Stockscreener 앱 받기
5.38
2.09%
0.11
시간 외 거래:
5.38
전일 마감가:
$5.27
열려 있는:
$5.25
하루 거래량:
1.65M
Relative Volume:
0.94
시가총액:
$1.11B
수익:
-
순이익/손실:
$-129.48M
주가수익비율:
-9.6347
EPS:
-0.5584
순현금흐름:
$-106.97M
1주 성능:
-7.72%
1개월 성능:
-5.45%
6개월 성능:
-3.93%
1년 성능:
+78.74%
1일 변동 폭
$5.14
$5.40
1주일 범위
$5.14
$5.98
52주 변동 폭
$2.92
$7.005
사바라 Stock (SVRA) Company Profile
명칭
Savara Inc
전화
51285113796
주소
6836 BEE CAVE ROAD, AUSTIN, TX
Compare SVRA vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
5.38 | 1.17B | 0 | -129.48M | -106.97M | -0.5584 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
사바라 Stock (SVRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 재개 | Oppenheimer | Outperform |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-11-13 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-02-15 | 개시 | JMP Securities | Mkt Outperform |
| 2023-11-07 | 개시 | Guggenheim | Buy |
| 2023-05-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-03-16 | 개시 | Piper Sandler | Overweight |
| 2021-03-15 | 개시 | Oppenheimer | Outperform |
| 2019-06-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | 재개 | ROTH Capital | Neutral |
| 2018-01-03 | 개시 | Ladenburg Thalmann | Buy |
| 2017-09-27 | 재개 | ROTH Capital | Buy |
| 2017-09-22 | 개시 | Jefferies | Buy |
| 2017-09-11 | 개시 | JMP Securities | Mkt Outperform |
모두보기
사바라 주식(SVRA)의 최신 뉴스
Walleye Capital LLC Invests $1.53 Million in Savara Inc. $SVRA - marketbeat.com
Savara (NASDAQ:SVRA) Stock Rating Lowered by Wall Street Zen - marketbeat.com
HC Wainwright Brokers Lower Earnings Estimates for Savara - marketbeat.com
Savara (NASDAQ:SVRA) Stock Price Down 5.4%What's Next? - marketbeat.com
HC Wainwright Has Pessimistic View of Savara FY2029 Earnings - marketbeat.com
How Investors Are Reacting To Savara (SVRA) Wider Q2 Loss And New US$108 Million Share Shelf - simplywall.st
SAVARA Q2 EPS USD -0.16 - moomoo.com
Savara Q2 loss widens to $40M on surging commercial costs - scanx.trade
Savara Inc (SVRA) Advances MOLBREEVI Launch Amid High Price-to-S - GuruFocus
Savara (NASDAQ:SVRA) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Savara Inc. Announces Q2 2026 Financial Results with Increased Net Losses - Kalkine Media
Savara Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Savara Q2 loss widens as operating expenses rise - TradingView
BRIEF-Savara Q2 Net Income USD -40.228 Million - TradingView
Savara Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
Savara (SVRA) Earnings Date and Reports 2026 - marketbeat.com
Savara Inc. $SVRA Shares Bought by Renaissance Technologies LLC - marketbeat.com
Savara Inc (YB4P.SG) recent insider transactions - au.finance.yahoo.com
Savara Inc (SVRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem With 88.90% Potential Upside - DirectorsTalk Interviews
Savara investors brace for earnings ahead of crucial FDA review By Investing.com - Investing.com Nigeria
Savara (SVRA) to Announce Quarterly Earnings on Wednesday - MarketBeat
SVRA Q2'26 Earnings: EPS estimate is (0.14) USD - TradingView
Savara: High-Potential Binary Bet Cruising To PDUFA After A 3 Month Speed Bump (SVRA) - Seeking Alpha
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Seven Fleet Capital Management LP Grows Stock Holdings in Savara Inc. $SVRA - marketbeat.com
Savara Inc. (SVRA) Gains 2% as Shares Test Key Resistance LevelsVolume Dry Up - dars.gov.et
Savara secures European, Australian patents for MOLBREEVI By Investing.com - Investing.com Nigeria
Savara Inc. (NASDAQ:SVRA) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
Savara Inc. $SVRA Shares Bought by Eversept Partners LP - marketbeat.com
SVRA|Savara Inc|Price:5.435|Chg%:-0.075 - TradingKey
Savara Inc (SVRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Savara Inc (SVRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Savara Inc (SVRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Savara Inc (SVRA) Institutional Confidence - TradingKey
Orbimed Advisors LLC Acquires Shares of 635,000 Savara Inc. $SVRA - marketbeat.com
Savara Inc (SVRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Savara Inc (SVRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Savara Inc. (SVRA) Q1 2026 Earnings: Net Loss Widens on Higher R&D Spend, Stock DipsDiluted EPS Report - dars.gov.et
Savara, Inc. Revenue Breakdown – NASDAQ:SVRA - TradingView
TradingKey - TradingKey
SVRA|Savara Inc|Price:5.510|Chg%:-0.240 - TradingKey
Affinity Asset Advisors LLC Decreases Stock Holdings in Savara Inc. $SVRA - marketbeat.com
Form 4 Savara Inc For: 24 July By Investing.com - Investing.com Nigeria
Savara Inc. CFO Robert Lutz Secures 70,000 Stock Options and 35,000 RSUs in Insider Transaction - Kalkine Media
Savara Inc (NASDAQ: SVRA) grants CFO 70,000 options, 35,000 RSUs - Stock Titan
Savara Inc. (SVRA) Edges Lower as Stock Approaches Critical Support at $5.37Demand Zone - dars.gov.et
SVRA Q1 2026 Earnings: Wider-than-Expected Loss Amidst Ongoing Clinical DevelopmentEarnings Revision Upgrade - dars.gov.et
ETFs Investing in Savara, Inc. Stocks - TradingView
사바라 (SVRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):